1. Home
  2. Clinical Topics
  3. FDA approves new imaging agent to help identify AD
Clinical TopicsDrugs and DevicesInfection PreventionWeb Exclusives

FDA approves new imaging agent to help identify AD

Share

A study of hospital-acquired infections (HAIs) in the ICU presented at the 22nd European Congress of Clinical Microbiology and Infectious Diseases found that inpatient mortality was significantly higher in patients with HAI compared to those without (13.2% vs. 1.1%). Read more.

Leave a Reply

Your email address will not be published.

Fill out this field
Fill out this field
Please enter a valid email address.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts